You have 9 free searches left this month | for more free features.

Condition

Hematological Malignancy (1)

Leukemia (1)

Lymphoma (1)

Myelodysplasia (1)

Myeloma (1)

Stem Cell Transplantation (1)

Overall Status

Completed (1)

Sign in for free

Phase

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer (1)

Collaborator

PETHEMA (Program for the Study and Treatment of Haematological Malignances) (1)

Intervention

glycopeptide (1)

piperacillin-tazobactam (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Observational (1)

glycopeptide

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus

Completed

Hematological Malignancy
+5 more

piperacillin-tazobactam
glycopeptide

Alcalá de Henares, Spain
+11 more

Nov 13, 2009